global perspectives on use of osimertinib in egfr nsclc
Published 5 years ago • 375 plays • Length 8:55Download video MP4
Download video MP3
Similar videos
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
7:45
upfront use of osimertinib in egfr nsclc
-
1:45
dr. ramalingam on the use of osimertinib in clinical trial and real-world settings
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
3:17
osimertinib in egfr-positive nsclc with brain metastases
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
6:06
osimertinib, the standard for egfr nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
1:53
resistance to osimertinib in egfr-mutated nsclc
-
1:06
dr. shum on patient consultation of osimertinib in nsclc
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
5:52
treatment of egfr nsclc after osimertinib
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc